Peanut Allergy Biotech Venture Secures $1.9m from NIAID to Submit IND & Head Toward Phase 1 Clinical Trial

Peanut Allergy Biotech Venture Secures $1.9m from NIAID to Submit IND & Head Toward Phase 1 Clinical Trial

A biotechnology company focusing on the development of food allergies received $1.9 million in funding for preclinical studies and product development, enabling preparations for a clinical trial concerning its lead program in peanut allergies. The company is Moonlight Therapeutics, Inc., and this funding was made possible via a Phase 2 Small Business grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The company’s proprietary treatment platform, TASIS—Targeted Allergen-Specific Immunotherapy within the Skin—involves applying small, minimally invasive skin stamps to deliver allergens to the skin’s immune cells and desensitize the patient from a food allergy over time. This dermal stamp is designed for at-home self-administration. It is applied only for a few minutes then discarded. The approach has shown encouraging results in animal models of peanut and other allergies.

Recently, Dr. Brian Vickery, Director of the Food Allergy Center at Emory’s and Children’s Healthcare in Atlanta, went on the record, “Moonlight Therapeutics is working on a treatment that has the potential to help address a signif...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee